This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Naohito Inagaki: Innovator in Pharmaceutical Chemistry
Introduction
Naohito Inagaki is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for specific biological pathways.
Latest Patents
Inagaki holds a patent for "4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors." This invention is crucial for advancing therapeutic strategies in treating various diseases. The compound is represented by a specific formula, where the components are defined in detail within the patent specification.
Career Highlights
Inagaki is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative drug development, contributing to the company's reputation for excellence in the pharmaceutical industry.
Collaborations
Inagaki has collaborated with notable colleagues, including Yoshiaki Isshiki and Yasunori Kohchi. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.
Conclusion
Naohito Inagaki's contributions to pharmaceutical chemistry, particularly through his patent on MEK inhibitors, highlight his role as an influential inventor in the field. His work continues to impact the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile